Breaking News Instant updates and real-time market news.

SGMO

Sangamo

$11.38 /

-0.25 (-2.15%)

16:02
05/04/21
05/04
16:02
05/04/21
16:02

Sangamo reports Q1 EPS (32c), consensus (30c)

Reports Q1 revenue $26.3M, consensus $23.98M. "This quarter, we have continued our focus on advancing our lead programs through clinical execution, regulatory interactions, and collaborations with our partners and investigators. We are pleased that enrollment has completed for Pfizer's lead-in study for the hemophilia A Phase 3 AFFINE trial. Additionally, the EMA granted Orphan Designation and the FDA granted Fast Track Designation to BIVV003, now known as SAR445136, our cell therapy product candidate treating sickle cell disease partnered with Sanofi. Also, we initiated the STEADFAST study for our product candidate treating renal transplant rejection, which we believe is the first-in-human CAR-Treg clinical study," said Sandy Macrae, CEO of Sangamo. "Further, our research engine continued to be highly productive this quarter, advancing both our CAR-Treg programs for autoimmune disorders and our transcriptional regulation therapies for neurological diseases."

  • 04

    May

  • 25

    May

SGMO Sangamo
$11.38 /

-0.25 (-2.15%)

05/03/21 RBC Capital
Sangamo initiated with an Outperform at RBC Capital
03/03/21 Wells Fargo
Sangamo price target lowered to $29 from $36 at Wells Fargo
01/05/21 Stifel
Sangamo initiated with a Hold at Stifel
12/16/20 H.C. Wainwright
Sangamo assumed with a Buy at H.C. Wainwright

TODAY'S FREE FLY STORIES

Recommendations
1Life Healthcare price target lowered to $55 from $61 at Citi » 06:11
05/13/21
05/13
06:11
05/13/21
06:11
ONEM

1Life Healthcare

$38.27 /

-0.49 (-1.26%)

Citi analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

05:03 Today Piper Sandler
1Life Healthcare earnings selloff a buying opportunity, says Piper Sandler
05/03/21 Jefferies
Jefferies confident in path to 'much larger' 1Life Healthcare, starts at Buy
05/03/21 Jefferies
1Life Healthcare initiated with a Buy at Jefferies
04/26/21 Piper Sandler
Piper Sandler 'incrementally bullish' on Amwell, Teladoc, 1Life
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

ONEM 1Life Healthcare
$38.27 /

-0.49 (-1.26%)

Hot Stocks
KBR awarded $51.2M NOAA contract » 06:11
05/13/21
05/13
06:11
05/13/21
06:11
KBR

KBR

$40.33 /

-0.36 (-0.88%)

KBR won a new $51.2M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KBR KBR
$40.33 /

-0.36 (-0.88%)

KBR KBR
$40.33 /

-0.36 (-0.88%)

04/21/21 Citi
KBR price target raised to $45 from $38 at Citi
03/29/21 DA Davidson
KBR price target raised to $40 from $30 at DA Davidson
03/26/21 Truist
KBR price target raised to $44 from $40 at Truist
02/23/21 Citi
KBR price target raised to $38 from $37 at Citi
KBR KBR
$40.33 /

-0.36 (-0.88%)

Upgrade
GrafTech upgraded to Outperform at RBC Capital on improving steel market » 06:11
05/13/21
05/13
06:11
05/13/21
06:11
EAF

GrafTech

$12.62 /

-0.17 (-1.33%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EAF GrafTech
$12.62 /

-0.17 (-1.33%)

EAF GrafTech
$12.62 /

-0.17 (-1.33%)

05:29 Today RBC Capital
GrafTech upgraded to Outperform from Sector Perform at RBC Capital
02/08/21 Citi
Citi upgrades GrafTech to Buy, doubles price target to $15
02/08/21 Citi
GrafTech upgraded to Buy from Neutral at Citi
EAF GrafTech
$12.62 /

-0.17 (-1.33%)

  • 02
    Mar
  • 15
    Jan
  • 15
    Dec
EAF GrafTech
$12.62 /

-0.17 (-1.33%)

Earnings
Natural Gas Services reports Q1 EPS (3c), consensus (8c) » 06:11
05/13/21
05/13
06:11
05/13/21
06:11
NGS

Natural Gas Services

$9.62 /

-0.08 (-0.82%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NGS Natural Gas Services
$9.62 /

-0.08 (-0.82%)

NGS Natural Gas Services
$9.62 /

-0.08 (-0.82%)

08/20/20 Maxim
Natural Gas Services price target raised to $12 from $7 at Maxim
NGS Natural Gas Services
$9.62 /

-0.08 (-0.82%)

Periodicals
Apple engineer out after employees call for investigation, The Verge reports » 06:10
05/13/21
05/13
06:10
05/13/21
06:10
AAPL

Apple

$122.82 /

-3.02 (-2.40%)

Top Apple engineer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

05/11/21 Evercore ISI
Chinese data points to smartphone market slowdown in April, says Evercore ISI
05/11/21 Bernstein
Mix shift to Pro/Pro Max behind Apple iPhone ASPs strength, says Bernstein
05/07/21 Northland
II-VI upgraded to Outperform from Market Perform at Northland
05/05/21 Bernstein
Bernstein sees modest financial consequence to Apple even with adverse rulings
AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

AAPL Apple
$122.82 /

-3.02 (-2.40%)

Hot Stocks
Becton Dickinson announces self-collection claim for HPV screening CE marked » 06:10
05/13/21
05/13
06:10
05/13/21
06:10
BDX

Becton Dickinson

$241.63 /

+0.49 (+0.20%)

Becton Dickinson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BDX Becton Dickinson
$241.63 /

+0.49 (+0.20%)

BDX Becton Dickinson
$241.63 /

+0.49 (+0.20%)

04/05/21 Argus
Weaker demand for Covid testing solutions to weigh on BD, says Argus
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
02/12/21 Wells Fargo
Wells Fargo sees only 'small chance' of positive FDA panel for Becton
02/05/21 Citi
Becton Dickinson price target raised to $280 from $273 at Citi
BDX Becton Dickinson
$241.63 /

+0.49 (+0.20%)

  • 21
    May
BDX Becton Dickinson
$241.63 /

+0.49 (+0.20%)

Earnings
National Vision reports Q1 adjusted EPS 48c, consensus 31c » 06:10
05/13/21
05/13
06:10
05/13/21
06:10
EYE

National Vision

$46.89 /

-3.11 (-6.22%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EYE National Vision
$46.89 /

-3.11 (-6.22%)

EYE National Vision
$46.89 /

-3.11 (-6.22%)

03/04/21 Citi
National Vision price target raised to $57 from $52 at Citi
03/03/21 Wells Fargo
National Vision price target raised to $55 at Wells Fargo after Q4 results
01/11/21 Loop Capital
National Vision downgraded to Hold from Buy at Loop Capital on valuation
01/11/21 Loop Capital
National Vision downgraded to Hold from Buy at Loop Capital
EYE National Vision
$46.89 /

-3.11 (-6.22%)

  • 04
    Mar
EYE National Vision
$46.89 /

-3.11 (-6.22%)

Initiation
HCA Healthcare resumed with a Neutral at Citi » 06:10
05/13/21
05/13
06:10
05/13/21
06:10
HCA

HCA Healthcare

$204.27 /

-2.23 (-1.08%)

Citi analyst Ralph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCA HCA Healthcare
$204.27 /

-2.23 (-1.08%)

HCA HCA Healthcare
$204.27 /

-2.23 (-1.08%)

04/26/21
Fly Intel: Top five analyst downgrades
04/26/21 BMO Capital
HCA Healthcare price target raised to $222 from $200 at BMO Capital
04/26/21 Citi
HCA Healthcare downgraded to Neutral from Buy at Citi
04/23/21 Raymond James
HCA Healthcare price target raised to $225 from $190 at Raymond James
HCA HCA Healthcare
$204.27 /

-2.23 (-1.08%)

HCA HCA Healthcare
$204.27 /

-2.23 (-1.08%)

Earnings
Fennec reports Q1 EPS (18c), consensus (13c » 06:09
05/13/21
05/13
06:09
05/13/21
06:09
FENC

Fennec

$6.01 /

-0.05 (-0.83%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FENC Fennec
$6.01 /

-0.05 (-0.83%)

04/21/21 Craig-Hallum
Fennec initiated with a Buy at Craig-Hallum
04/19/21 Maxim
Fennec initiated with a Buy at Maxim
04/19/21 Maxim
Fennec initiated with a Buy at Maxim
08/12/20 Wedbush
Fennec price target lowered to $11 from $18 at Wedbush
FENC Fennec
$6.01 /

-0.05 (-0.83%)

Recommendations
NIO notes chip shortage remains key production constraint, says Citi » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
NIO

NIO

$33.67 /

-1.195 (-3.43%)

Citi analyst Jeff Chung…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

05/11/21 Wedbush
Tesla April China deliveries see some softness, China tensions key, says Wedbush
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
05/03/21 Morgan Stanley
NIO on track for Q2 target after April deliveries, says Morgan Stanley
05/03/21 Mizuho
NIO price target raised to $65 from $60 at Mizuho
NIO NIO
$33.67 /

-1.195 (-3.43%)

  • 14
    Dec
  • 31
    Aug
  • 11
    Jun
NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

NIO NIO
$33.67 /

-1.195 (-3.43%)

Earnings
Haemonetics sees FY22 adjusted EPS $2.60-$3.00, consensus $3.48 » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
HAE

Haemonetics

$59.85 /

+0.225 (+0.38%)

Sees FY22 revenue up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

04/20/21 Raymond James
CSL's Haemonetics contract end due to Terumo agreement, says Raymond James
04/20/21 Jefferies
Jefferies says 'premature' to permanently exclude CSL as Haemonetics customer
04/20/21 Morgan Stanley
Haemonetics downgraded to Equal Weight from Overweight at Morgan Stanley
04/20/21 Needham
Haemonetics price target lowered to $108 from $158 at Needham
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

Upgrade
Albemarle upgraded to Sector Perform from Underperform at RBC Capital » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
ALB

Albemarle

$154.71 /

-5.575 (-3.48%)

RBC Capital analyst Arun…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

05:29 Today RBC Capital
Albemarle upgraded to Sector Perform from Underperform at RBC Capital
05/12/21 Wells Fargo
Albemarle price target raised to $175 from $162 at Wells Fargo
05/10/21 Citi
Albemarle price target raised to $191 from $174 at Citi
05/07/21
Fly Intel: Top five analyst upgrades
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

  • 04
    Feb
ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

ALB Albemarle
$154.71 /

-5.575 (-3.48%)

Earnings
MultiPlan sees 2021 revenue $1.04B-$1.10B, consensus $1.03B » 06:08
05/13/21
05/13
06:08
05/13/21
06:08
MPLN

MultiPlan

$6.15 /

-0.655 (-9.63%)

Sees 2021 Adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
03/19/21 Barclays
MultiPlan initiated with an Equal Weight at Barclays
03/11/21 Citi
Citi 'scratching our heads' over MultiPlan not issuing 2021 guidance
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

Hot Stocks
Second Sight announces year three NIH funding of Orion study » 06:07
05/13/21
05/13
06:07
05/13/21
06:07
EYES

Second Sight

$6.31 /

+1.35 (+27.22%)

Second Sight announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

EYES Second Sight
$6.31 /

+1.35 (+27.22%)

Earnings
MultiPlan reports Q1 EPS 7c, consensus 1c » 06:07
05/13/21
05/13
06:07
05/13/21
06:07
MPLN

MultiPlan

$6.15 /

-0.655 (-9.63%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

04/07/21 B. Riley
B. Riley starts MultiPlan at Buy, sees 'meaningful investment opportunity'
04/06/21 B. Riley
MultiPlan initiated with a Buy at B. Riley
03/19/21 Barclays
MultiPlan initiated with an Equal Weight at Barclays
03/11/21 Citi
Citi 'scratching our heads' over MultiPlan not issuing 2021 guidance
MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

MPLN MultiPlan
$6.15 /

-0.655 (-9.63%)

Upgrade
First Hawaiian upgraded to Neutral from Sell at UBS » 06:06
05/13/21
05/13
06:06
05/13/21
06:06
FHB

First Hawaiian

$27.01 /

-1.21 (-4.29%)

UBS analyst Brock…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FHB First Hawaiian
$27.01 /

-1.21 (-4.29%)

FHB First Hawaiian
$27.01 /

-1.21 (-4.29%)

11/19/20 JPMorgan
First Hawaiian price target raised to $18.50 from $15.50 at JPMorgan
07/07/20
Fly Intel: Top five analyst downgrades
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
07/07/20 Wells Fargo
First Hawaiian downgraded to Underweight from Equal Weight at Wells Fargo
FHB First Hawaiian
$27.01 /

-1.21 (-4.29%)

Hot Stocks
Yeti CEO says 'exceptional start to the year' » 06:06
05/13/21
05/13
06:06
05/13/21
06:06
YETI

Yeti

$81.51 /

-6.12 (-6.98%)

Matt Reintjes, President…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

05/12/21 BTIG
Yeti price target raised to $100 from $90 at BTIG
05/11/21 Piper Sandler
Yeti price target raised to $97 from $95 at Piper Sandler
05/10/21 Baird
Yeti price target raised to $100 from $87 at Baird
05/04/21 Jefferies
Yeti price target raised to $115 from $100 at Jefferies
YETI Yeti
$81.51 /

-6.12 (-6.98%)

  • 28
    May
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

Downgrade
Athene Holding downgraded to Neutral from Buy at UBS » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
ATH

Athene Holding

$60.37 /

-2.08 (-3.33%)

UBS downgraded Athene…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

05/10/21 RBC Capital
Athene Holding price target raised to $60 from $55 at RBC Capital
04/14/21 Oppenheimer
Apollo Global upgraded to Outperform at Oppenheimer
04/06/21 RBC Capital
Athene Holding price target raised to $55 from $48 at RBC Capital
04/05/21
Fly Intel: Top five analyst downgrades
ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

ATH Athene Holding
$60.37 /

-2.08 (-3.33%)

Earnings
Haemonetics reports Q4 adjusted EPS 46c, consensus 67c » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
HAE

Haemonetics

$59.85 /

+0.225 (+0.38%)

Reports Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

04/20/21 Raymond James
CSL's Haemonetics contract end due to Terumo agreement, says Raymond James
04/20/21 Jefferies
Jefferies says 'premature' to permanently exclude CSL as Haemonetics customer
04/20/21 Morgan Stanley
Haemonetics downgraded to Equal Weight from Overweight at Morgan Stanley
04/20/21 Needham
Haemonetics price target lowered to $108 from $158 at Needham
HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

HAE Haemonetics
$59.85 /

+0.225 (+0.38%)

Periodicals
Tesla Model 3 driver arrested for operating car from back seat, WSJ reports » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
TSLA

Tesla

$590.12 /

-26.78 (-4.34%)

The California Highway…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

05/12/21 JPMorgan
JPMorgan says reports on Tesla halting Shanghai expansion are inaccurate
05/11/21 Piper Sandler
Piper says 'hard to draw meaningful conclusions' from 'messy' Tesla China data
05/11/21 Wedbush
Tesla April China deliveries see some softness, China tensions key, says Wedbush
05/10/21 Wedbush
Tesla demand looks robust so far in Q2 despite rising competition, says Wedbush
TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

TSLA Tesla
$590.12 /

-26.78 (-4.34%)

Recommendations
Vroom price target lowered to $58 from $60 at Piper Sandler » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
VRM

Vroom

$35.44 /

-1.4 (-3.80%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRM Vroom
$35.44 /

-1.4 (-3.80%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

04/13/21 Wedbush
Vroom added to Best List Ideas at Wedbush
04/07/21 Raymond James
Raymond James starts Vroom at Outperform on digital auto secular growth
04/07/21 Raymond James
Vroom initiated with an Outperform at Raymond James
03/04/21 Truist
Vroom price target lowered to $54 from $58 at Truist
VRM Vroom
$35.44 /

-1.4 (-3.80%)

  • 07
    Dec
  • 11
    Sep
  • 09
    Jun
VRM Vroom
$35.44 /

-1.4 (-3.80%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

VRM Vroom
$35.44 /

-1.4 (-3.80%)

Upgrade
Funko upgraded to Buy from Neutral at BofA » 06:05
05/13/21
05/13
06:05
05/13/21
06:05
FNKO

Funko

$21.27 /

-2.11 (-9.02%)

BofA analyst Alexander…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FNKO Funko
$21.27 /

-2.11 (-9.02%)

FNKO Funko
$21.27 /

-2.11 (-9.02%)

05/07/21 Truist
Funko price target raised to $25 from $18 at Truist
05/07/21 DA Davidson
Funko upgraded to Buy from Neutral at DA Davidson
05/07/21 DA Davidson
Funko upgraded to Buy from Neutral at DA Davidson
04/19/21 JPMorgan
Funko price target raised to $25 from $20 at JPMorgan
FNKO Funko
$21.27 /

-2.11 (-9.02%)

FNKO Funko
$21.27 /

-2.11 (-9.02%)

FNKO Funko
$21.27 /

-2.11 (-9.02%)

FNKO Funko
$21.27 /

-2.11 (-9.02%)

Recommendations
Chipotle price target raised to $2,100 from $2,000 at Piper Sandler » 06:04
05/13/21
05/13
06:04
05/13/21
06:04
CMG

Chipotle

$1,342.58 /

-50.05 (-3.59%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

05/10/21 Stephens
Chipotle will quickly raise prices to offset wage hike, says Stephens
04/27/21 RBC Capital
Chipotle price target raised to $1,750 from $1,730 at RBC Capital
04/23/21 Deutsche Bank
Chipotle price target raised to $1,495 from $1,462 at Deutsche Bank
04/22/21 Evercore ISI
Chipotle price target raised to $1,725 from $1,650 at Evercore ISI
CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

CMG Chipotle
$1,342.58 /

-50.05 (-3.59%)

Earnings
Yeti raises FY21 adjusted EPS view to $2.28-$2.32 from $2.11-$2.14 » 06:02
05/13/21
05/13
06:02
05/13/21
06:02
YETI

Yeti

$81.51 /

-6.12 (-6.98%)

FY21 consensus $2.17.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

05/12/21 BTIG
Yeti price target raised to $100 from $90 at BTIG
05/11/21 Piper Sandler
Yeti price target raised to $97 from $95 at Piper Sandler
05/10/21 Baird
Yeti price target raised to $100 from $87 at Baird
05/04/21 Jefferies
Yeti price target raised to $115 from $100 at Jefferies
YETI Yeti
$81.51 /

-6.12 (-6.98%)

  • 28
    May
YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

YETI Yeti
$81.51 /

-6.12 (-6.98%)

Initiation
Coinbase initiated with a Neutral at Compass Point » 06:02
05/13/21
05/13
06:02
05/13/21
06:02
COIN

Coinbase

$283.50 /

-19.35 (-6.39%)

Compass Point analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
COIN Coinbase
$283.50 /

-19.35 (-6.39%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

05/10/21 Oppenheimer
Oppenheimer starts Coinbase at Outperform with $434 price target
05/10/21 Oppenheimer
Coinbase initiated with an Outperform at Oppenheimer
05/04/21
Fly Intel: Top five analyst initiations
05/04/21 Mizuho
Coinbase price target raised to $315 from $285 at Mizuho
COIN Coinbase
$283.50 /

-19.35 (-6.39%)

  • 14
    Apr
COIN Coinbase
$283.50 /

-19.35 (-6.39%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

COIN Coinbase
$283.50 /

-19.35 (-6.39%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.